Fundamental analysis · SEC EDGAR · TTM through 30/06/2026
MMM · NYSE · Healthcare
Fundamental quality
60
out of 100
3M Co is a mature, stable business: it earns money solidly (net margin 11.9%) but grows slowly (-4.4% a year). On fundamental quality it scores 60 out of 100, profiling it as a company of reasonable quality. Its weakest area is its growth (revenue -4.4%/yr). Whether it's cheap or expensive depends on the current price, which you can compute in the tool.
3M is the thousand-product industrial conglomerate: adhesives, abrasives, medical supplies, Post-its. Years of multibillion-dollar litigation (military earplugs, PFAS chemicals) forced a deep restructuring and a dividend cut.
EPS growth: -8.8% · Revenue growth: -4.4%
Net margin: 11.9% · ROE: 101.5% · ROIC: 28.4%
Net debt/EBITDA: 1.6x · FCF: 15.8%
Source: SEC EDGAR · TTM through 30/06/2026
The score combines growth, profitability and financial strength. Here its financial strength weighs in its favor, while its growth drags it down the most.
Percentile against the other 57 Healthcare companies in our coverage: how far it beats them on each metric (100 = best in sector).
Computed from the daily dataset scores. A high percentile places the company among the best in its sector on that metric; it is not a buy recommendation.
Key concepts
What do these metrics mean? Fundamental analysis · What is the P/E · What is EPS · What is ROE · Net & gross margin · Free cash flow
| Year | Revenue | Net income | Free cash flow | Net debt |
|---|---|---|---|---|
| 2020 | 32,184 | 5,449 | 6,612 | 14,149 |
| 2021 | 35,355 | 5,921 | 5,851 | 12,783 |
| 2022 | 26,161 | 5,777 | 3,842 | 12,284 |
| 2023 | 24,610 | -6,995 | 5,065 | 8,307 |
| 2024 | 24,575 | 4,173 | 638 | 7,444 |
| 2025 | 24,948 | 3,250 | 1,396 | 7,367 |
Between 2020 and 2025, revenue went from $32,184M to $24,948M (-22%) and net income went from $5,449M to $3,250M (-40%). Meanwhile, its margins have narrowed (from 17% to 13%).
Annual figures in millions of U.S. dollars ($M) per SEC filings. Net debt is total debt minus cash.
Latest results
Figures for the half-year ended June 30, 2026, versus the half-year ended June 30, 2025 (SEC filings):
Compared with the previous close (March 31, 2026), this is what moved in its accounts:
Automatic comparison between the two most recent periods filed with the SEC. One quarter doesn't make a trend: read it alongside the historical evolution above.
$2.92
per share, yearly
48.1% of earnings
Payout
The dividend yield depends on today's price. Compute it in the analyzer → · See all dividend-paying stocks →
Open your account in minutes with regulated brokers and buy U.S. and European stocks from small amounts. No paperwork.
The serious investor's standard
Open free account →Anyone who wants low commissions and access to almost any market in the world.
Popular in the U.S.
Open free account →Anyone investing in the U.S. who wants a powerful, commission-free stock app.
Investing carries risk of loss.
Is 3M Co cheap or expensive?
That depends on the current price. Look it up, enter it in the tool and get the full valuation verdict (P/E against its sector).
Compute the valuation →Is 3M Co a good company to invest in?
In terms of business quality, 3M Co scores 60 out of 100 in our analysis, placing it as a company of reasonable quality. That said, this isn't a recommendation: whether it's a good investment also depends on its current price and your goals.
Is 3M Co a profitable company?
Yes. 3M Co shows a net margin of 11.9% and an ROE of 101.5%, a sign of a profitable business.
Does 3M Co have a lot of debt?
A moderate level: its net debt is 1.6 times its EBITDA.
Is 3M Co growing?
Its revenue has fallen 4.4% annualized in recent years.
Does 3M Co generate cash?
Yes. It converts about 15.8% of its revenue into free cash flow, and has done so positively year after year.
The thresholds are general and the system doesn't judge qualitative factors. See the full methodology and use this analysis as a first filter, never as a final decision.
More Healthcare companies
Cigna (CI) · Elevance Health (ELV) · McKesson (MCK) · Zoetis (ZTS) · CVS Health (CVS) · HCA Healthcare (HCA) · see more →
Who's behind the methodology and model · how the score is computed
Data: see 3M Co's filings on EDGAR
Spotted a figure that looks wrong? Report it and we'll review it.